263 related articles for article (PubMed ID: 36938207)
1. Spotlight on the Mucormycosis Outbreak: A Deadly Fungal Infection That Followed the COVID-19 Pandemic.
Patel SN; Shah S; Panchal J; Desai C; Upadhya IB; Patel M
Cureus; 2023 Feb; 15(2):e35095. PubMed ID: 36938207
[TBL] [Abstract][Full Text] [Related]
2. Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.
Kamath S; Kumar M; Sarkar N; Ahmed T; Sunder A
Cureus; 2022 Jan; 14(1):e21054. PubMed ID: 35155019
[TBL] [Abstract][Full Text] [Related]
3. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India.
Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D
J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
5. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
[TBL] [Abstract][Full Text] [Related]
6. Post COVID-19 Mucormycosis-The Horizon.
J JAT; Reddy LS
Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):517-522. PubMed ID: 36540726
[TBL] [Abstract][Full Text] [Related]
7. Mucormycosis, Diabetes and COVID-19 Pneumonia: Unleashing the Facts.
Shastri M; Raval DM; Patel D; Patel AB; Chopra A; Rathod VM; Dobariya R; Patel NS; Patel NH; Patel A; Gohel DM
Cureus; 2022 Sep; 14(9):e29555. PubMed ID: 36312629
[TBL] [Abstract][Full Text] [Related]
8. Emergence of Cerebral Mucormycosis in the Post-COVID Period: A Detailed Analysis of Risk Factors, Clinical Progression, and Management of This Opportunistic Fungal Infection.
Patel M; Panchal J; Desai C; Shah J; Prajapati B; Patel S
Cureus; 2022 Nov; 14(11):e31220. PubMed ID: 36514560
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.
Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P
Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223
[TBL] [Abstract][Full Text] [Related]
10. COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review.
Balushi AA; Ajmi AA; Sinani QA; Menon V; Berieki ZA; Shezawi AA; Azri SA; Rashdi AA; Jardani AA; Baluki TA; Ghaithi SA; Reesi AA; Al-Za'abi AT; Al' Balushi MA; Maqbali TA
Int J Infect Dis; 2022 Aug; 121():203-210. PubMed ID: 35533833
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center.
Mrig S; Sardana K; Arora P; Narula V; Arora S; Kapoor A; Baruah RR; Sen P; Agarwal S; Sachdeva S; Dewan A; Panesar S
Am J Otolaryngol; 2022; 43(3):103465. PubMed ID: 35429848
[TBL] [Abstract][Full Text] [Related]
12. COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series.
Singh S; Basera P; Anand A; Ozair A
Cureus; 2022 Aug; 14(8):e27906. PubMed ID: 36110469
[TBL] [Abstract][Full Text] [Related]
13. Post-Covid Cerebral Mucormycosis, Varied Presentations and Surgical Strategies of a Newer Epidemic: An Institutional Experience.
Vijayasekhar MV; Nagappa V; Swaroop KH; Mithun G; Achuith E; Varaprasad KS
Neurol India; 2022; 70(3):1052-1056. PubMed ID: 35864638
[TBL] [Abstract][Full Text] [Related]
14. Mucor in a Viral Land: A Tale of Two Pathogens.
Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
[TBL] [Abstract][Full Text] [Related]
15. Clinical Study of Surge of Mucormycosis in COVID-19 Pandemic: A Tertiary Care Center Study.
Gupta DP; Gupta S; Shah CK; Sreevidya SR
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3455-3462. PubMed ID: 34367936
[TBL] [Abstract][Full Text] [Related]
16. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
[TBL] [Abstract][Full Text] [Related]
17. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
[No Abstract] [Full Text] [Related]
18. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
19. Mucormycosis in COVID-19 pandemic: study at tertiary hospital in India.
Chavan RP; Ingole SM; Nazir HA; Desai WV; Kanchewad GS
Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3201-3210. PubMed ID: 35122509
[TBL] [Abstract][Full Text] [Related]
20. The changing trend of fungal infection in invasive rhinosinusitis in the COVID era.
Garg P; Ranjan V; Avnisha ; Hembrom S; Goel S; Malhotra S
J Family Med Prim Care; 2024 Apr; 13(4):1428-1433. PubMed ID: 38827671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]